These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8244980)
1. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. Tanizawa A; Beitrand R; Kohlhagen G; Tabuchi A; Jenkins J; Pommier Y J Biol Chem; 1993 Dec; 268(34):25463-8. PubMed ID: 8244980 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture. Tanizawa A; Pommier Y Cancer Res; 1992 Apr; 52(7):1848-54. PubMed ID: 1312902 [TBL] [Abstract][Full Text] [Related]
3. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. Rubin E; Pantazis P; Bharti A; Toppmeyer D; Giovanella B; Kufe D J Biol Chem; 1994 Jan; 269(4):2433-9. PubMed ID: 8300570 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line. Chan VT; Ng SW; Eder JP; Schnipper LE J Biol Chem; 1993 Jan; 268(3):2160-5. PubMed ID: 8380592 [TBL] [Abstract][Full Text] [Related]
5. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Fujimori A; Harker WG; Kohlhagen G; Hoki Y; Pommier Y Cancer Res; 1995 Mar; 55(6):1339-46. PubMed ID: 7882333 [TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Tamura H; Kohchi C; Yamada R; Ikeda T; Koiwai O; Patterson E; Keene JD; Okada K; Kjeldsen E; Nishikawa K Nucleic Acids Res; 1991 Jan; 19(1):69-75. PubMed ID: 1849260 [TBL] [Abstract][Full Text] [Related]
8. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin. Chang JY; Liu JF; Juang SH; Liu TW; Chen LT Cancer Res; 2002 Jul; 62(13):3716-21. PubMed ID: 12097280 [TBL] [Abstract][Full Text] [Related]
10. Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line. Kubota N; Kanzawa F; Nishio K; Takeda Y; Ohmori T; Fujiwara Y; Terashima Y; Saijo N Biochem Biophys Res Commun; 1992 Oct; 188(2):571-7. PubMed ID: 1332703 [TBL] [Abstract][Full Text] [Related]
11. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. Knab AM; Fertala J; Bjornsti MA J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753 [TBL] [Abstract][Full Text] [Related]
13. Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin. Tanizawa A; Kohn KW; Pommier Y Nucleic Acids Res; 1993 Nov; 21(22):5157-66. PubMed ID: 8255771 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. Knab AM; Fertala J; Bjornsti MA J Biol Chem; 1993 Oct; 268(30):22322-30. PubMed ID: 8226741 [TBL] [Abstract][Full Text] [Related]
15. Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations. Urasaki Y; Takebayashi Y; Pommier Y Cancer Res; 2000 Dec; 60(23):6577-80. PubMed ID: 11118036 [TBL] [Abstract][Full Text] [Related]
16. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037 [TBL] [Abstract][Full Text] [Related]
17. Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance. Yanase K; Sugimoto Y; Andoh T; Tsuruo T Int J Cancer; 1999 Mar; 81(1):134-40. PubMed ID: 10077164 [TBL] [Abstract][Full Text] [Related]
18. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Holm C; Covey JM; Kerrigan D; Pommier Y Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Madden KR; Champoux JJ Cancer Res; 1992 Feb; 52(3):525-32. PubMed ID: 1310066 [TBL] [Abstract][Full Text] [Related]
20. Identification of the gene encoding DNA topoisomerase I from Candida albicans. Taylor A; Giles K; Sarthy AV; McGonigal T; Fostel J FEMS Microbiol Lett; 1996 May; 138(2-3):113-21. PubMed ID: 9026437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]